Arkansas Testosterone Injury Lawyer Discusses Liability of Low-T Drug Makers for Heart Attack Side Effects

Thousands of upset men and their families look forward to October 2016 when the first testosterone lawsuit will be tried as a bellwether trial. They feel cheated by the makers of androgel, androderm, and similar low-T supplement makers who sold them “the fountain of youth” only to harm them. Our Arkansas testosterone injury lawyer is currently evaluating fact patterns where plaintiffs had strokes, heart attacks, and even paralysis within months of taking these patches, gels, and injections containing the androgenic hormone.

A majority of the more than 2,000 testosterone heart attack lawsuits are against seven manufacturers, who account for about 90 percent of the $2 billion “disease sold” to consumers every year. The direct promo pitch for testosterone replacement without informing its side effects promises to restore youthful energy and overturn a sagging libido in men unsure of hypogonadism, the disease treated with these drugs. Misinformation is even forcing healthy middle-aged men to reverse normal aging effects. Those swayed by these disease mongering ads suffered from blood clots, heart attacks, and arterial blockages to death.

Cheated, Harmed by Low-T Makers

Daniel Weber, a 44-year-old resident from Fort Smith, Arkansas, took to Low-T supplements after TV ads forced him to think that he had testosterone deficiency. The promos never divulged that the drugs are only for those with hypigonadism and not for age-related decrease in the sex hormone. The ads neglected to mention the drugs could have side effects. His Arkansas testosterone injury lawyer claims that he had a stroke after having the low-T gel therapy for about seven months. He became partially paralyzed and diagnosed with lung embolism.

The low-T lawsuit filed by this Arkansas resident blames Androgel, the supplement he used to improve testosterone levels, for his condition. In March this year, the FDA announced changes to the drug label to include warning about potential thromboembolic events, clots, and strokes in those using testosterone supplements. There are countless stories telling heart attack side effects linked to low-T injections, gels, patches and other forms of supplements.

Studies Negate Low-T Supplement Makers, Warns Side Effects

A recent finding reported in the Journal of the American Medical Association negates the manufacturer’s claim of restoration of youthful vigor and sexual appetite following testosterone replacement therapy. Researchers discovered no assured “improvement in overall sexual function, partner intimacy, and health-related quality of life” after these supplements are used. This may leave many users to face only heart attack risks without any benefit. A 2013 report in the same journal was scathing in its attack on supplement makers for their unethical promotional campaign that misled healthy men on diseases treated with these drugs.

Multiple studies reported in the last two years warned about a clear increase in the risk of cardiac problems and death in older men treated with low-T drugs.

FDA Needs Assurance on Safety

Low-T supplements have been on the market since the 1950s, but the market started expanding manifold in the 2000s. AbbVie, the maker of Androgel, reported about four million users of low-T products in 2000. The numbers grew five times in 2003 and over 25 times by 2014. One of the litigants claims that “the number of men with the conditions for which AndroGel is indicated, which are believed to be substantially smaller” and the most of the users are driven by lifestyle purposes. And the reason? AbbVie had spent close to $150 million in promotions in 2012 and 2013.

The March 2015 warning by the FDA acknowledged side effects that many plaintiffs and consumer groups have been complaining of for years. In August, the New England Journal of Medicine published a research report prepared by the FDA’s Office of Drug Evaluation. The report expressed concerns over abuse of low-T supplements by men without “classic hypogonadism” symptoms and called for more safety trials. The agency also issued a statement after reviewing several complaints and findings. “Testosterone is being used extensively in attempts to relieve symptoms in men who have low testosterone for no apparent reason other than aging and the benefits and safety of this use have not been established,” reads the statement.

The FDA also acknowledges that at least 28% of users take the supplements without any testing. “Given these patters of use, it appears that a majority of men prescribed testosterone may have age-related hypogonadism rather than classic hypogonadism and the findings is troubling in light of evidence from recent large observational studies that suggests potential cardiovascular risk associated with testosterone use,” it observed.

Contact us or call on 1-800-632-1404 for evaluation of your potential low-T lawsuit claim by our Arkansas testosterone injury lawyer.

October 15, 2015

Testosterone Heart attack Concerns Continue, Study Evaluates Low-T Supplements for Risks

As a Tennessee testosterone injury lawyer, we have been taking keen interest in exploring association between cardiovascular risks and low-T supplements ever since the first revelations took the nation by storm. There has been widespread allegation against manufactures over direct-to-consumer promotions and “selling of a non-existent disease” for profits. While abuse of testosterone supplements is known to cause heart attack and strokes, a recent study has made a comparative analysis of degree of threat posed by various types of low-T drugs.

JAMA Report on Evaluation of Low-T Supplement Risks

According to a report published in the JAMA Internal Medicine, low-t injections carry the highest cardiovascular complication risk compared to patches and gels. Based on the research by scholars from the Chapel Hill-based University of North Carolina, the study is a direct acknowledgement of heart attack and stroke risks, fatal incidents, and hospitalizations associated with testosterone drugs.

The study took into account half-a-million records obtained from insurance and Medicare claims between 2000 and 2012 both in the United States and United Kingdom. Researchers identified different types of low-T products – patch (7% users), gel (56%), and injections (37%) – used by subjects and evaluate their medical history reported within 180 days of the therapy.

The risk of heart complications, including thromboembolic events, strokes, unstable angina, and heart attack, was found to be higher in those taking low-T injections. User were at 26 percent higher risk of developed these complications. They have 16 percent more chance of being hospitalized and 32 percent more danger of death from heart problems compared to gels and patches, which also caused disturbing cardio problems.

Testosterone Heart Risk

In July, a Tennessee man sued Androgel maker AbbVie claiming that his father died due to blood clots and stroke associated with the low-T supplement therapy. The deceased man, aged 65, took Androgel after analyzing his condition according to the questionnaire on the manufacturer website. He had no prior history of heart attack and he was encouraged by the makers to use the supplement for lifestyle improvement, the TN lawyer representing the low-T lawsuit claims. Complications were visible in eight months and he died.

Recent revelations by over 2,000 Androgel and other low-T lawsuits filed across the country highlight deep vein thrombosis, death, heart attack, and sudden stroke following testosterone replacement therapy. The $2-billion low-T market allegedly stands on an aggressive marketing campaign and misinformation on the safety of supplements. Men misinformed by manufacturers mistake natural fall in testosterone as a disease and use low-T patches, gel, and injections that effects cardiac problems.

In November 2013, a report in the Journal of the American Medical Association was first to highlight cardiovascular adverse events in older men using low-T drugs. It opened the stage for litigation and hundreds of testosterone heart attack lawsuits were filed in Tennessee and other states. The trend continues with increasing consumer awareness. Three months later, PLoSOne published a study claiming that low-T supplement users aged 65 and above at two-fold greater risk of heart attack and stroke. Another study reported by Pharmacotherapy journal in 2015 warned of 40 percent increase in the possibility of heart attack.

In March 2015, the FDA added new label warnings on heart attack, blood clot, blockages, and strokes. Last month, the regulator asked the manufacturers to have more clinical trials to validate the safety data.

Contact us or call on 1-800-632-1404 for evaluation of your potential low-T lawsuit claim by our Tennessee testosterone injury lawyer. We have the experience and expertise in handling Androgel and other low-T supplement lawsuits.

September 16, 2015

Tennessee Testosterone Lawyer Discusses Androgel Testosterone Lawsuit Evaluation

Low T Lawyer — Testosterone lawsuits claim blood clots, heart attack, and stroke due to Low-T drug side effects.

A surge in the filing of Tennessee testosterone lawsuits in the last one year brings to notice how manufacturers duped consumers and sold disease in the name of reversing normal effects of aging and restoring youthful vigor. Escalating side effect complaints corroborated by mounting research evidence and rising product liability lawsuits have busted the myth of testosterone as fountain of youth. Now it is the time to pay back the low-T drug makers who put monetary benefits above your health and run misinformation campaigns for commercial gains.

The $2 billion testosterone market founded on “direct-to-consumer campaign and unethical selling of a fake disease” caused thousands of incidents of blood clots, heart attack, stroke, or cardiac complications in unsuspecting low-T drug users. The law empowers Tennessee men and their families to file to testosterone Androgel product liability lawsuits and seek compensatory and punitive financial damages for their suffering and medical expenses. They too have a duty to initiate legal action against makers of Androgel, Testim, Androderm, and other low-T supplements and ensure their accountable to consumer safety. Explore your options for product liability during no cost, no obligation consultation with a Tennessee testosterone lawyer.

Testosterone Therapy Lawsuit filed by Tennessee Testosterone Lawyer

The family of a 52-year-old filed a Tennessee testosterone lawsuit a few months ago claiming wrongful death. The victim started using Androgel after going through an online quiz on the manufacturer’s website that encourages mid-life males to identify if they are low on testosterone and require using the supplement. Though such promotion is a blatant violation of medical ethics, it influences men on seeking a testosterone boost. The lawsuit was filed by a Tennessee testosterone lawyer.

The victim suffered from blood clots and had recurrent heart attacks within 11 months. He had no cardiac problem before he began taking Androgel. His family came to know about the risk of heart attack and stroke after FDA highlighted “increased risk of heart attack, blood clots, consequent venous thromboembolism, deadly arterial blockages, and stroke with use of testosterone products for low testosterone due to aging.”

The Tennessee Androgel lawsuit is among more than 2,000 testosterone product liability claims filed against low-T drug makers.

Testosterone Therapy Not Beneficial, Claims Study

According to the latest research findings reported by the Journal of the American Medical Association last week, low-T supplements do not guarantee “improvement in overall sexual function, partner intimacy, and health-related quality of life” in users. The study also calls for much larger study on the heart attack risk linked to testosterone supplements.

Researchers from Havard experimented with 300 men above 60 years and suffering from low level of testosterone. Divided into two groups, one was treated with low-T supplements while the other was put under placebo medication for three years. The results suggested no significant improvement in those given low-T supplements compared to non- testosterone treatment as far as the quality of life and sexual functions are concerned. The study rejected the claim of manufacturers promoting testosterone therapy as beneficial to improve lifestyle and sexual orientation.

In 2013, the JAMA journal published a commentary criticizing the low-T supplement manufacturers for creating a terming age-related natural change as a disease to promote sell of their products. In 2014, TIME published a report where medical professionals questioned “whether testosterone products are safe or if they even revitalize men like they promise to.”

Contact us or call on 1-800-632-1404 for evaluation of your potential testosterone lawsuit claim by a Tennessee testosterone lawyer.

July 24, 2015

Testosterone Therapy Risk: Are Manufacturers Selling A “Fake Disease”?

Are makers of Androgel, Androderm, Abbvie, Axiron, and other testosterone therapy drugs selling diseases instead of medications? A testosterone lawsuit filed recently is the latest in the series of litigations highlighting the way manufacturers use direct-to-consumer ad campaigns to convince consumers about the need for testosterone therapy medications. Manufacturers have “made up” a fake disease – mislead consumers on the age-related natural decrease in testosterone citing it as a health disorder – through advertisements and forcing people to seek medications they hardly ever need. There is indeed a Testosterone Therapy Risk to those who ingest the drug.

The testosterone lawsuit argues that “aggressive marketing campaign by manufacturers encouraged men to discuss testosterone replacement therapy with their doctors and consumers and their physicians relied on manufacturers’ promises of safety, effectiveness and east of use.” A fort-five-year-old man swayed by manufacturer’s campaign went for Androgel to improve his age-related fall in testosterone levels. He had two heart attacks within a year of having the gel-based testosterone therapy. The user had no prior cardiovascular problem and he developed blood clots after six months of the gel use. Our Tennessee testosterone therapy lawyer has also come across many such stories where ads played a role in “misinforming men to go for prescriptions they didn’t need” and in causing them to bear the brunt of testosterone therapy heart attack side effects.

JAMA Commentary Blames Low-T Drug Ads Campaign

The ever increasing number of testosterone lawsuits claiming blood clot and cardiovascular side effects are being filed every month and research studies also bring into the notice the flipside of ad campaign by low-T drug makers. In 2013, a commentary in the JAMA Internal Medicine journal entitled “Low ‘T’: How to Sell Disease” made a scathing attack on the marketing practice of low-T drug makers citing how unethical selling of a fake disease drives the $2 billion annual sale of these drugs.

The report was based on the pattern of testosterone therapy sought by 11 million men and discovered that a majority of these were “convinced that they suffered from low testosterone” and used medications without any test. Their primary source of reliance on low-t drugs is “driven, in large part, by direct-to-consumer marketing campaigns.” These ads are so pervasive that many over 40 years are readily thinking that they have a little bit of testosterone and they must use testosterone therapy to prevent losing the youth and vitality.

The notable example is how AbbVie sells Androgel, the low-T drug most targeted through testosterone lawsuits. Its ads highlight impacts of falling T levels and a miracle cure with the drug. The dedicated Low-T website run by the drug maker has “an online quiz sure to make most mid-life males muse about the benefits of a testosterone boost.” Riding on this, Androgel gives AbbVie a billion dollar in revenue every year.

While making such ads, manufacturers forget that their medication is to treat clinical symptoms of hypogonadism, the condition of abnormally low testosterone, which affects only a small number of people. The ads suppress the fact that decrease in T level is natural with age and marshal drugs as the holy grail of sex, muscular body, energy, positive mood, and lifestyle enhancement. Thus healthy men using testosterone therapy are turning unhealthy due to side effects.

The commentary termed such efforts to spin the drug benefits through unbalanced presentation of ‘facts’ as “a mass, uncontrolled experiment, which invites men to expose themselves to the harms of a treatment unlikely to fix problems which they may not really have.”

Manufacturers Selling Drugs Despite Knowing Risks

The evidence of cardiovascular problems associated with low-T drugs first came into light in November 2013 a research report cited 30 percent rise in heart attack risks. Based on VA Eastern Colorado Health Care data, the JAMA report led to filing of testosterone lawsuits. This was followed by NY Times and Wall Street Journal reports claiming that drug makers suppressed safety data on the medications for about a decade. In 2009, NIH called off a trial after many patients treated with testosterone therapy developed blood clots and heart problems.

Persistent pressure by consumer watchdogs forced the FDA to announce a probe that resulted in warning by the federal regulator about “increased risk of heart attack and stroke with use of testosterone products for low testosterone due to aging.” A recent analysis in the Journal of the American Geriatrics Society terms low- T drug advertising as “the mass marketing component of disease mongering of age-related declines in testosterone.”

Contact us or call on 1-800-632-1404 for evaluation of your potential testosterone lawsuit claim by our experienced Tennessee testosterone therapy lawyer.

July 13, 2015

Testosterone Heart Attack Lawsuit in Arkansas: FAQs

Over 1,500 testosterone heart attack lawsuits have been filed citing fatal and non-fatal blood clotting and cardiovascular complications following testosterone therapy. All types of low-T products, including gels, injections, and patches, of various make and brand are cited for adverse events. The following information compiled by our Arkansas testosterone therapy lawyer is an attempt to educate those seeking to file litigation against testosterone drug makers for compensatory damages.

Do I have a testosterone heart attack lawsuit?

You can file a testosterone lawsuit for unwarned and unexpected side effects, such as blood clots and heart complications, associated with low-T drugs. Manufacturers may be liable for selling unsafe products and not disclosing adverse events their products are capable of doing.

Why are there testosterone heart attack lawsuits?

A large number of testosterone heart attack lawsuits have been filed in the last two years seeking product liability for fatal and non-fatal side effects, such as, blood clotting, heart attacks, stroke, arterial blockage, kidney and liver problems, diabetes, and metabolic disorders.

Plaintiffs and their lawyers claim that low-T drug makers never disclosed about the harmful impacts of the drugs. Instead, the promotional campaigns highlight these medications as significant to enhance energy, muscular body, sexual desire, and mood linked to falling testosterone levels.

Consumer groups and research reports also continue to question attempts by low-T medication makers to interpret natural decrease in the testosterone level with age progression as akin to health disorder and promoting their drugs as a solution to reverse it.

What are most reported testosterone heart attack risks/injuries?

Testosterone therapy is known to cause blood clots, thromboembolic events, pulmonary embolism, heart attack, and stroke. The FDA has warned about “increased risk of heart attack, blood clots, consequent venous thromboembolism, deadly arterial blockages, and stroke with use of testosterone products for low testosterone due to aging.”

Why do men face enhanced testosterone heart attack?

Testosterone therapy is to treat hypogonadism or abnormal low testosterone due to inability of gonads to produce it. However, many men influenced by misguiding advertisements mistake age-related natural decrease in testosterone as a disorder and start using low-T medications to enhance life style. Such unnecessary use causes blood clots and results deadly arterial blockages, heart attack, and strokes.

Is there any research on testosterone heart attack risk?

A November 2013 JAMA medical journal report warned of 29 percent greater threat of heart complications in people using testosterone therapy.
A 2013 Chicago Tribune Business report cautioned about two-time higher heart attack and stroke risk in low-T drug users following a meta-analysis of more than two dozen studies.
According a 2014 report in PLOSOne journal, users are 36% more predisposed to have heart problems. The threat is two-time more for those above 65.
A 2013 report in the NY Times claim five-fold more heart attack risk.

Who should I sue in a testosterone heart attack lawsuit?

The drug manufacturers may be liable for not disclosing safety information about their products or for selling defective products.

Is there any statute of limitations for testosterone heart attack lawsuit?

Yes. Consult with an expert Arkansas testosterone therapy lawyer to know your chances of filing a claim.

What are the compensations victims can claim?

Plaintiffs can seek compensation, including

financial losses due to injury, such as medical cost
non-financial costs, such as wage loss
punitive damages
compensation for loss of family life, suffering, etc

Why should I consult a personal injury lawyer?

The help of an Arkansas testosterone therapy lawyer is vital to evaluate your claim, prepare a strong claim for compensation, file the lawsuit with the statute of limitations, and arrange expert testimony. Your lawyer may also become an asset for your during settlement negotiations.

What will a Testosterone Heart Attack Lawsuit cost?

Contact us or call on 1-800-632-1404 for evaluation of your potential claim by our experienced Arkansas testosterone therapy lawyer. We offer to fight testosterone lawsuits on no-win, no-fee basis and charge a fee only when we win the litigation and succeeded in getting compensation for our clients.

March 4, 2015

Tennessee Xarelto, Effexor, Testosterone and Zoloft Injuries

The following are the most talked about defective drug lawsuits that dominated medical litigations scenario in 2014 and continue to be in the news in 2015. If you are a Tennessee resident (or from another state), please contact us to see if we can help.

Xarleto Lawsuit

Will Xalerto lawsuit go Pradax way? The blockbuster blood thinner promoted as a safe and secure alternative has been linked to irreversible and uncontrolled internal bleeding. About 200 deaths and 680 adverse events caused by the drug between January and May 2014 make it one of the most reported medications with side effects in 2014. At least 150 patients died and another 2100 suffered injuries following the drug ingestion in 2013.

Over 30 Xalerto lawsuits are pending in the federal court system. A multidistrict litigation has been established in a Louisiana Eastern District court. The number of lawsuits may go into thousands, as Xalerto are evaluating large number of wrongful death and injury claims associated with the anticoagulant.

Over 4,000 Pradaxa lawsuits filed against its maker Boehringer Ingelheim were settled in May 2014 for $650 million. In December 2014, the USMDL ordered pre-trial centralization of two dozens of Xarelto lawsuits filed in 10 different states in the court of Judge Eldon E. Fallon of Louisiana Eastern District.

Testosterone Therapy Lawsuit

In 2015, testosterone therapy lawsuit may emerge as the most talked about defective drug litigation. With millions of consumer using these supplements available in gel, patches, and pills are steadily being educated about heart attack risks and how manufacturers sell them diseases in the name of drugs.

Low-T supplements when used for lifestyle purposes have the potential to cause blood clotting, strokes, heart attack, and even death. Researchers have also linked these sex-boosting hormones to colon cancer, diabetes and metabolic problems, blockages, kidney problems, and liver disorders.

With about 300 lawsuits filed and many in the pipeline, testosterone therapy lawyers expect the litigation to grow in to thousands of Androgel lawsuits, Andrderm lawsuits, Testim lawsuits, Depo-Testosterone lawsuits, Axiron lawsuits, and Testopel lawsuits. The first Androgel lawsuit is expected to go for trial in October 2016, according to the MDL case management order by Illinois Judge Matthew Kennelly.

Zoloft Lawsuit

Zoloft lawyers were busy throughout 2014 evaluating birth defect claims linked to the drug ingestion by pregnant women. This year is expected to keep them busy with further with the steady expansion of the MDL centralized at the court of Judge Cynthia M. Rufe of Pennsylvania.

Zoloft antidepressant, according to plaintiffs and researchers, results in deformities, malformations, and life-threatening disorders in newborns, including

Fatal lung and respiratory problems
Heart defects requiring life-long surgical interventions
Brain and cranial malformations
Spine and neural tube defects
Sever neurological and physical defects

Pfizer, manufacturer of the SSRI antidepressant, has been defending over 500 Zoloft lawsuits seeking product liability for not disclosing the drug’s pregnancy-linked adverse events. Children, as young as three weeks, have undergone open heart surgeries following serious heart attacks caused by prenatal exposure to the drug.

Effexor Lawsuit

The coining of the word “ Effexor Baby” by medical professionals demonstrates how catastrophic are side effects of SSRI and SNRI antidepressants when ingested during pregnancy. The drug, one of the most prescribed drugs, has forced thousands of expectant mothers to rethink over taking antidepressants to save their baby from the impacts of their mental stress and depressive disorders.

Effexor side effects include fatal persistent pulmonary hypertension that causes just-born babies to die of sudden respiratory failure. Hypoplastic heart and other cardiovascular defects not only require surgical interventions at a tender age, but also severe compromise their quality of life. Delayed development, neurological disorders, and limb deformities are also common in such children

At least 100 Effexor lawsuits have been filed in the last six months. The litigation is expected to grow manifold and become one of the most prominent defective drug lawsuits in the coming days.

To know about the process for filing Effexor lawsuit, Zoloft lawsuit, Xalerto lawsuit, Androgel lawsuit or similar defective drug injury claims seeking product liability for drug maker’s actions and inactions, please contact us or call on 1-800-632-1404.

March 4, 2015

Androgel Lawsuit Claims Testosterone Therapy Heart Attack Side Effects

Call A Testosterone Attorney @ 1-800-632-1404

FREE CASE EVALUATION: CALL 1-800-632-1404

Have you suffered from heart attack following Androgel testosterone therapy? Call on 1-800-632-1404 and contact our drug injury lawyers to evaluate and file an Androgel Lawsuit seeking product liability against AbbVie and Abbot.

An Androgel lawsuit filed by a 52-year-old Illinois resident claims that he suffered from heart attacks after using the most-sold testosterone replacement therapy drug. John started taking the gel-based low-T drug in December 2012. He, much like two million Americans using the drug, was influenced by “ads that aimed at older men” with slogans “feeling tired, irritable, lost your sex drive? Try our testosterone product.”

Within eight months, side effects of Androgel, the supposed fountain of his youth and vigor, turned his him into a heart patient for life. John suffered from two heart attacks, first in July 2013 and the second a month later. He has no prior heart problem, but developed blood clots after using the testosterone therapy. He became aware of the exact cause of his medical condition after the Journal of the American Medical Association published a report claiming 29 percent higher risk of heart attack linked to Androgel and similar Low-T supplements. This followed a PLOSOne report (January 2014) that showed how healthy men became subject of adverse cardiovascular events following testosterone therapy.

John began consulting his Androgel attorney after the FDA issued a formal warning in June 2014 citing “of blood clots and consequent venous thromboembolism or deadly arterial blockages,” a key reason of heart attack, associated with Low-T drugs, gels, patches, and other supplements.

Earlier, five men initiated the first of Androgel lawsuits in February 2014 against drug maker AbbVie and Abbot claiming that the Low-T supplement was “a defective product with serious propensity to harm.” Their testosterone therapy lawsuits came within a week of FDA decision to review all sex-hormone enhancing medications, including Androgel. Filed in a Chicago federal court, the litigations claimed that the drug manufacturer “deceived potential AndroGel users by relaying positive information through the press, including testimonials from retired professional athletes, while downplaying known adverse and serious health risks.”

Of the five plaintiffs, all aged between 50 and 63, two hard strokes and three suffered heart attacks linked to the drug use, according to the Androgel attorney representing them.

Androgel Lawsuit: Know Your Claim

A majority of about 300 testosterone therapy lawsuits filed in the US federal courts are initiated by Androgel attorneys representing claims. Originally introduced in 2000, testosterone topical gel is available in two versions, AndroGel 1% and AndroGel 1.62%, and sales exceeding $1 billion a year. The drug is the most used Low-T supplement in the United States.

Despite the FDA caution that the drug is only for those suffering from hypogonadism, not age-related testosterone decrease, off-label use of it is rampant primarily because of direct-to-consumer promotion by the manufacturer, a claim espoused by every Androgel attorney. A whistleblower litigation is pending against AbbVie highlighting the same.

Using low-t drugs for lifestyle purposes may prove harmful with fatal side effects. Androgel lawsuits and research findings relate the drug to adverse events, including

Serious blood clotting events, such as deep vein thrombosis and pulmonary embolism
Stroke
Heart Attack
Adverse cardiovascular events
Wrongful death
Increased hypertension
Elevated red blood cell count
Sleep apnea

A recent report published in the Proceedings of the National Academy of Sciences warns of colon cancer risk in men using supplements to boost testosterone sex hormone.

The preponderance of Androgel lawsuits has led to two separate orders, one for the consolidation of litigations involving the drug and the other for non-Androgel testosterone therapy lawsuits. The first Androgel trial is expected to start on October 31, 2016.

To Contact a Testosterone Lawyer:

If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

March 3, 2015

Testosterone Attorney Says New Study Supports Testosterone Therapy Heart Attack Risk

FREE CASE EVALUATION: CALL 1-800-632-1404

A recent research report published in the Pharmacotherapy journal has suggested “statistically significant association between first-time testosterone use and heart attack risk.” The findings are significant for a testosterone attorney evaluating adverse events and wrongful death claims. Some reports blame supplement makers for hiding side effect information for profits, and there has been a surge in testosterone therapy lawsuits against makers of Anrogel, Testim, and similar low-t drugs.

According to the latest findings, men using testosterone replacement therapy for the first time are more likely to suffer from heart problems than those not using it. Made public on January 13, 2015, the report prepared by scholars from the British Columbia University pegs the risk as 40 percent higher. The study involved examination of medical records of about “1 million men from ages 45-80.”

Reports Blame Drug Makers for “Hiding” Testosterone Heart Attack Risk

A number of testosterone therapy heart attack lawsuits seek compensation claiming that they have been defrauded by drug manufacturers.

An August 2013 report in the Journal of the American Medical Association entitled Low “T”: How to Sell Disease, documented extensively efforts by testosterone supplement producers to manipulate consumers through influenced doctors, sales representatives, marketing promotions, unproven claims, and funded studies into using their Low-T products even if there is no need of it. It called for greater vigilance and research before using the therapy. It expressed alarm at the growing use of testosterone replacement therapy for lifestyle reasons, sex drive, and strength gain and a failure of the pharmaceutical industry to warn about its side effects.

The New York Times reported on February 3, 2014, that supplement manufacturers were aware of serious testosterone heart attack risk nearly a decade earlier than users and the medical professionals highlighted it. It hinted at results of a clinical trial conducted by Boston-based researchers in the early 2000’s that discovered a five-fold rise in testosterone heart attack risk.

Researchers administered Low-T medications to hundreds of men and found considerable enhancements in their energy and strength levels. However, most of them were diagnosed with testosterone-linked cardiovascular complications, such as enhanced risk of stroke and heart attack. It was discovered that those taking testosterone therapy were five-time more susceptible to heart attack than those treated with placebo. The study continued until 2010 without any public disclosure of findings and manufacturers have been aggressively marketing sell Low-T supplements without cardiovascular disorder information.

The Endocrine Society, a body of endocrinology experts in the United States, has called for safety assessment studies on the heart attack risk posed by testosterone therapy. Many consumer groups and experts are critical of aggressive marketing Low-T supplements despite complaints of serious cardiovascular risks in users.

All these findings have reinforced the contention of a testosterone attorney and plaintiffs filing lawsuits that the manufacturer suppressed risk data for commercial gains.

Testosterone Therapy Heart Attack

Testosterone therapy causes a significant increase in risk of heart attack and consequent death risk when administered to seniors or younger men with potential cardiovascular problems. The major cardiovascular complications associated with testosterone therapy are:

Heart attack
Stroke
Blood clots leading to arterial disruptions or Pulmonary Embolism

The Journal of the American Medical Association reported a potential link between testosterone therapy and heart attack risk in November 2013 that resulted in many users seeking to file product liability lawsuits. On January 31, 2014, the FDA announced an investigation into the risk of heart attack, stroke, and other cardiovascular disorders associated with testosterone therapy.

A recent study reported in the PLOS ONE medical journal warns of a close association between heart attack and use of testosterone gel, patch, and other supplements. Published on January 29, 2014, the report highlights that seniors without history of cardiovascular disorder and young men with previous cardiac complications face 36 percent more risk of heart attacks when using the testosterone therapy.

If you are victim of similar injures or suffered adverse events linked to Low- T drugs, contact us or call on 1-800-632-1404 for evaluation of your potential low-t drug injury claim by our experienced testosterone attorney.

To Contact a Testosterone Lawyer:

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

December 12, 2014

Testosterone Therapy May Result in a Testosterone Lawsuit

FREE CASE EVALUATION: CALL 1-800-632-1404

The upswing in testosterone lawsuit filing and research reports warning of fatal heart attack risks associated with Low-T drugs have woken up medical regulatory authorities. The European Medicines Agency has called for limiting prescription of testosterone drugs to the treatment of verified hypogonadism and avoiding using them to benefit lifestyle. In September, two FDA committees made similar recommendations that forced the US federal regulator to seek additional data on the testosterone blood clotting side effects.

The EMA warning came after its Pharmacovigilance Risk Assessment Committee called for regular safety review and monitoring of testosterone therapy heart attack risks. “Testosterone levels naturally fall somewhat with age, but restoration of these levels in healthy older men is not an authorized use of the medicine and manufacturers should update the product information in line with the latest evidence and to provide warnings about those who might be at an increased risk of heart problems,” reads the EMA’s statement issued on November 21.

“The product information should make it clear that testosterone should only be used when an abnormally low level of the hormone has been confirmed by signs and symptoms and appropriate laboratory tests,” says the agency. The assertion comes in the backdrop of allegations that manufacturers are resorting to direct-to-consumer marketing and advertising their drugs as an effective mean to counter falling energy and sex drive due to the aging process.

Though the European agency did not reach any conclusive evidence on the association between testosterone therapy and heart attacks and blood clots, it suggested continued “research, monitoring, and regular safety review” of such adverse events. The regulator also advised men with heart, liver, or kidney disorders to avoid testosterone drugs.

FDA Calls For Safety Review

Two FDA panels, Drug Safety and Risk Management Committee and Bone, Reproductive, and Urologic Drugs Committee, met in September to assess testosterone side effect injury complaints. After consulting with various experts, the two panels suggested regulatory direction to force manufacturers for “additional trials to evaluate the side effects of testosterone drugs on mens’ hearts.”

Held in the backdrop of rising number of testosterone lawsuits, both meetings called for efforts to prevent Low-T drug use for “life style reasons” and restrict their prescription to actual illness. It called for strict measures to reduce use of the medications to overcome natural drop in testosterone level as the age progresses and even suggested civil fines on drug makers for noncompliance.

Testosterone Therapy Side Effect Risks

With a majority of over three million men using Low-T drugs to meet lifestyle needs, testosterone attorneys expect a large number of side effect injury lawsuits in the coming years. Research studies indicate a higher chance of adverse cardiovascular events in men receiving testosterone boosters despite having normal levels or without proper diagnosis of required medical condition. While these drugs are overprescribed, over 90 percent users are using these medications without proper test readings.

The most common injuries associated with testosterone therapy include,

Blood clots
Heart attack
Stroke
Pulmonary embolism
Wrongful death
Metabolic disorder
Kidney and liver problems

In February 2014, the New York Times made a startling claim that manufacturers had suppressed information related to testosterone therapy heart attack side effects for over a decade. A 2013 report in the Journal of American Medical Association attacked Low-T drug makers for “selling diseases” through advertisements “designed to convince men that they suffered from low testosterone” even if there was no required medical condition.

Testosterone Lawsuit

Over 200 testosterone lawsuits have been centralized at an Illinois federal court for pretrial consolidations. The first Androgel lawsuit bellwether trial is expected to start in the second half of 2016. While researchers continue to identify and evaluate potential risks associated with testosterone therapy, attorneys specializing in drug injury litigations are busy evaluating prospective claims.

If you are victim of similar injures or suffered adverse events linked to Low- T drugs, contact us or call on 1-800-632-1404 for evaluation of your potential testosterone lawsuit by our experienced drug injury lawyers.

To Contact a Testosterone Lawyer:

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?

November 21, 2014

Testosterone Lawsuit Crosses 200 Mark Amid Rising Concern Over Drug Abuse

FREE CASE EVALUATION: CALL 1-800-632-1404

With media and research reports suggesting stroke and wrongful death as potential Low-T supplement side effects, there has been a spurt in testosterone lawsuit filings in the last nine months. At least 223 claims have been filed against makers of Androgel, Androderm, Depo-Testosterone, Testim, and other supplements by mid October 2014. Consumer groups are worried over increasing abuse of these drugs attributed to direct-to-buyer marketing practices by makers while studies have warned of enhanced testosterone blood clot and prostate cancer risks.

Testosterone Lawsuit

According to MDL records made public, testosterone heart risk lawsuits rose from 177 to 223 as of October 15, 2014. The complaints represent victims who have suffered heart attacks and strokes following blood clotting side effects of Low-T drugs. A significant number of AndroGel lawsuits share allegations highlighting how the supplement maker AbbVie misled consumers about its adverse impacts. A 49-year-old plaintiff from Georgia endured three heart attacks within a year of using the testosterone replacement gel. The drug used for a little over 20 weeks led a 58-year-old New York man to experience a massive heart attack. Another 60-year-old died of heart failure following use of Auxilium’s Testim gel for months.

All victims did not have any previous history of cardiovascular or diabetes problems, and they went for AndroGel hormone replacement to enhance their low sex drive and falling energy level, two signs highlighted by manufacturer-sponsored ad campaigns as key indications of depleted testosterone level.

The USJPML selected Illinois Northern District Court Judge Matthew Kennelly for pretrial consolidation and centralization of all Low-T litigations, including Androgel lawsuit, Androderm lawsuit, Axiron lawsuit, Depo-Testosterone lawsuit, Testim lawsuit, and similar claims. On October 24, a court order allowed direct filing of new individual claims in the MDL, which eliminates procedural and time delays and allows judicial efficiency in speeding up the proceedings.

The pharmaceutical industry reports indicate the possibility of such litigations running into thousands as testosterone lawyers across the country busy evaluating large number of heart attack, stroke, pulmonary embolism, and similar injury claims associated with gels, creams, patches or injections used for Low-T replacement therapy. Supplement manufacturers gained $2 billion in sales in 2013.

Testosterone Therapy Heart Attack Risk

Men using testosterone replacement therapy face the increased risk of

blood clots (polycythemia thickens blood; thromboxane production enhances platelet aggregation)
heart attack (36% greater risk and those already with heart problems and above 65 face two-time higher risk within 90 days, reported PLOSOne journal in January 2014)
risk of wrongful death due to stroke (29% more risk, claims the JAMA journal in November 2013; five-timer higher risk NYT 2013)
rampant abuse without medical need (JAMA, July 2013)
pulmonary embolism or blockage (FDA advisory, January 2014 and Health Canada advisory July 2014)
diabetes and metabolic problems
worsening of existing kidney and liver disorders

In October 2014, a new study reported in Endocrinology journal warns of prostate cancer in testosterone therapy users. Attributed to scholars from Chicago-based Illinois University, it linked Low-T supplements to low-risk of prostate tumors and high risk of enhancing effect of cancer-causing agents.

At the recent FDA advisory panel meet, the Endocrine Society warned of severe side effects in men using testosterone replacement therapy without being diagnosed for hypogonadism. Its guidelines published in the Journal of Clinical Endocrinology & Metabolism flayed the practice of using these drugs to boost lifestyle.

Men unaware of adverse ramifications and induced by deceptive ad campaigns resort to using testosterone replacement therapy to reverse the effects of natural aging. This, in turn, left them with cardiovascular and metabolic problems that require life-long dietary restrictions and medical care.

To Contact a Testosterone Lawyer:

CALL: 1-800-632-1404

FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:

Your Name (required)

Your Email (required)

Your Phone Number (required)

Case Details

1+1=?